The study conducted by the National Children's Medical Center in Uzbekistan evaluates the use of autologous platelet-rich fibrin (PRF) in bladder exstrophy repair, a rare pediatric condition. With a small patient population of 20, the trial aims to demonstrate a reduction in postoperative complications, particularly penopubic fistula formation. If successful, this could position PRF as a valuable adjunct in pediatric urology, potentially expanding its application in other surgical contexts. The market for advanced wound healing products is growing, driven by increasing surgical procedures and a focus on reducing complications. However, the limited scope of this trial may restrict immediate commercial viability without further studies to validate findings across larger populations. Competitive analysis should consider existing biological and synthetic alternatives in wound healing.